 |
|
|
|
|
|
|
|
|
|
| |
 |
Workshops
|
|
|
| |
 |
Upcoming Workshops and Training Sessions
|
|
|
| |
|
Safety and Scientific Symposia
|
|
|
| |
|
Safety Symposium - March 15, 2005
Current Perspectives on Gene Transfer for X-SCID
|
|
|
| |
|
Safety Symposium - September 21-22, 2004
Safety Considerations in Recombinant DNA Research with Pathogenic Viruses
|
|
|
| |
|
Safety Symposium - March 7, 2001
Safety Considerations in the Use of AAV Vectors in Gene Transfer Clinical Trials
|
|
|
| |
|
Safety Symposium - December 14, 2000
Safety Considerations in Cardiovascular Gene Transfer Clinical Research
|
|
|
| |
|
Safety Symposium - March 8, 2000
Internally Deleted, Helper-Dependent Adenoviral Vectors
|
|
|
| |
|
Biosafety Considerations for Research with Lentiviral Vectors |
|
|
| |
|
Policy Conferences
|
|
|
| |
|
Summaries and Reports of the Gene Therapy Policy Conferences (1998-Present)
|
|
|
| |
|
IBCs in a Changing Research Landscape: A Policy Conference
|
|
|
| |
|
Professional Development Conferences, Workshops, and Training Sessions
|
|
|
| |
|
The NIH System of Oversight of Human Gene Transfer Research: Optimizing Science, Safety and Ethics
|
|
|
| |
|
IBC Basics: An Introduction to the NIH Guidelines and the Oversight of Recombinant DNA Research
|
|
|
| |
|
The Future Face of IBCs: Evolving Roles and Responsibilities, Upcoming Challenges and Opportunities
|
|
| |
|
|
|
|
Upcoming Workshops and Training Sessions |
|
|
| |
OBA will be conducting workshops, training sessions, and presentations at the following meetings:
|
|
|
| |
|
The Three I's - Harmonization: Two full days of innovative ideas and proven strategies for IACUCs, IBCs & IRBs, Massachusetts Society for Medical Research, Tempe, Arizona, March 5-6, 2009
|
|
|
| |
|
IBC Basics, Public Responsibility in Medicine and Research, San Diego, California, March 28, 2009
|
|
|
| |
|
Institutional Biosafety Committees: Promoting Optimal Practice for Today and Tomorrow,
June 24-26, Hyatt Regency, Crystal City, Virginia
|
|
|
| |
|
The NIH Office of Biotechnology Activities and the Eagleson Institute, with the participation of the American Association for Laboratory Animal Science, American Biological Safety Association, American Society for Microbiology, and Public Responsibility in Medicine and Research, are planning a professional development conference for Institutional Biosafety Committee members and staff. The conference will also be of interest to biosafety professionals, research administrators, scientists, and others involved with recombinant DNA research. An agenda for the conference will be posted on this site in the near future. In the meantime, for more information, contact the Eagleson Institute at 207-490-1076.
|
|
Top of Page |
|
|
|
|
Safety Symposium - March 15, 2005: |
|
|
| |
Current Perspectives on Gene Transfer for X-SCID
|
|
|
| |
|
Webcast - Morning session before break |
|
|
| |
|
Webcast - Morning session after break |
|
|
| |
|
Webcast - Afternoon session before break |
|
|
| |
|
Webcast - Afternoon session after break |
|
|
| |
|
Current Perspectives on Gene Transfer for X-linked Severe Combined Immunodeficiency Disease (X-SCID) |
|
Top of Page |
|
|
|
|
Safety Symposium - September 21-22, 2004: |
|
|
| |
Safety Considerations in Recombinant DNA Research with Pathogenic Viruses
|
|
|
| |
On September 21-22, 2004, NIH OBA held a safety symposium in conjunction with the meeting of the Recombinant DNA Advisory Committee (RAC). The symposium addressed safety considerations for recombinant DNA research with pathogenic viruses, focusing on containment issues for research with such viruses as 1918 influenza virus, highly pathogenic avian influenza viruses, and SARS Co-V. A major goal of the symposium was to develop a Points to Consider document and other resources to assist IBCs in conducting risk assessments and determining appropriate containment.
|
|
|
| |
|
Agenda and Participant List |
|
|
| |
|
Webcast - Day one - Morning session before break |
|
|
| |
|
Webcast - Day one - Morning session after break |
|
|
| |
|
Webcast - Day one - Afternoon session before break |
|
|
| |
|
Webcast - Day one - Afternoon session after break |
|
|
| |
|
Reference Information |
|
|
| |
|
Frequently Asked Questions - Risk Assessment and Determining Containment |
|
Top of Page |
|
|
|
|
Safety Symposium - March 7, 2001: |
|
|
| |
Safety Considerations in the Use of AAV Vectors in Gene Transfer Clinical Trials
|
|
|
| |
|
Transcript |
|
Top of Page |
|
|
|
|
Safety Symposium - December 14, 2000: |
|
|
| |
Safety Considerations in Cardiovascular Gene Transfer Clinical Research
|
|
|
| |
|
Transcript |
|
Top of Page |
|
|
|
|
Safety Symposium - March 8, 2000: |
|
|
| |
Internally Deleted, Helper-Dependent Adenoviral Vectors
|
|
|
| |
|
Transcript |
|
|
| |
|
Summary |
|
Top of Page |
|
|
|
|
Summaries and Reports of the Gene Therapy Policy Conferences (1998-Present) |
|
|
| |
Prenatal Gene Therapy: Scientific, Medical, & Ethical Issues - January 7-8, 1999 |
|
|
| |
|
Full Report |
|
|
| |
|
Summary |
|
|
| |
|
RAC Statement Regarding In Utero Gene Transfer Research |
|
|
| |
Lentiviral Vectors for Gene Delivery - March 9, 1998 |
|
|
| |
|
Summary |
|
|
| |
|
Preclinical Safety Evaluation of Lentivirus Vectors: FDA Regulatory Expectations - Anne M. Pilaro, Ph.D. |
|
Top of Page |
|
|
|
|
"IBCs in a Changing Research Landscape: A Policy Conference" |
|
|
| |
Bethesda, Marriott, December 7-8, 2001
|
|
|
| |
|
Conference Summary |
|
|
| |
|
Webcasts Day 1
|
|
|
| |
|
Welcome |
|
|
| |
|
Session 1 |
|
|
| |
|
Session 2 |
|
|
| |
|
Session 3 |
|
|
| |
|
Session 4 |
|
|
| |
|
Webcasts Day 2
|
|
|
| |
|
Morning Session |
|
|
| |
|
Afternoon Session |
|
